<DOC>
	<DOC>NCT02836522</DOC>
	<brief_summary>The purpose of this study is to finalize development of a questionnaire that measures health-related symptoms and concerns for persons diagnosed with, and either treated or monitored for, anal pre-cancer lesions.</brief_summary>
	<brief_title>Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)</brief_title>
	<detailed_description />
	<mesh_term>Squamous Intraepithelial Lesions of the Cervix</mesh_term>
	<criteria>Consented to the ANCHOR trial as per selfreport and by providing a valid referral code on the information sheet provided by the referring site. Both men and women from the ANCHOR trial will be recruited to this study. English fluent as we are only validating this measure in English at this time At least one month posttreatment for anal HSIL as per selfreport, or if the person is in the ANCHOR trial observation arm, then at least one month post randomization. Has a scheduled ANCHOR followup appointment in the next two weeks as per self report. The purpose of this exclusion criterion is to minimize the impact on a participant's responses to a posttest evaluation the potential occurrence of an interim diagnosis or treatment event, or anxiety related to an upcoming medical followup.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Health-Related Symptom Index</keyword>
	<keyword>ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)</keyword>
</DOC>